UCB1381 Disease area studied Abbreviated title Phase Study ID Registry database Study results Plain language summary Publication (if available) Atopic Dermatitis A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B) Phase1/2 UP0110 Ongoing NCT05277571
